Andere talen Bioxyne Limited

Aandelen

BXN

AU000000BXN6

Beurs gesloten - Australian S.E. Andere beurzen 07:31:42 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,006 ^AUD	0,00%		-25,00%	-45,45%

29/02	Bioxyne Limited rapporteert resultaten voor het halfjaar dat eindigde op 31 december 2023	CI
05/02	Bioxyne ontvangt licentie voor de productie van medische cannabis en MDMA; aandelen stijgen met 50%.	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Bioxyne to Raise AU$1.45 Million via Share Issuance	18/04
Bioxyne Limited Reports Earnings Results for the Half Year Ended December 31, 2023	29/02
Bioxyne Receives License to Manufacture Medical Cannabis, MDMA; Shares Up 50%	05/02
Bioxyne Limited Announces Retirement of N H Chua as Director	17/11
Bioxyne Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31-08-23
Bioxyne Unit Joins Forces to Launch B2B Cannabis Trading Platform in Australia; Shares Slump 11%	15-08-23
Bioxyne Limited Extends Amazon Footprint into US and Japan	17-07-23
Australian Shares Track Gains of Wall Street Peers Ahead of Inflation Data, Policy Meetings	13-06-23
Bioxyne Launches Online Healthcare with Technology Partner InstantScripts; Shares Decline 8%	13-06-23
Bioxyne Limited Appoints Jason Hine as Director	23-05-23
Bioxyne Acquires Breathe Life Sciences	22-05-23
Bioxyne Limited acquired Breathe Life Sciences Pty Ltd.	19-05-23
Bioxyne Proceeds With Breathe Life Sciences Acquisition; Shares Fall 4%	20-03-23
Bioxyne Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-23
Bioxyne's Fiscal H1 Revenue Declines	27-01-23
Bioxyne to Acquire Health, Wellness Peer Breathe Life Sciences; Shares Gain 4%	19-12-22
Bioxyne Limited entered into a binding term Sheet to acquire Breathe Life Sciences Pty Ltd for AUD 32 million.	19-12-22
Bioxyne Limited Announces Joining of Mr. Sam Watson the Board as Joint Chief Executive Officer	18-12-22
Bioxyne Sells 49% Stake in Direct Selling Business	24-10-22
Paramount Star Investments Limited reached agreement to acquire 49% of Direct Selling Business of Bioxyne Limited from Bioxyne Limited for $1 million.	24-10-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Bioxyne Limited

Aandelen

BXN

AU000000BXN6

Andere talen

Filters